105 related articles for article (PubMed ID: 31402566)
1. Plasma galectin-3 levels do not differ in systemic lupus erythematosus patients.
Zhao CN; Mao YM; Liu LN; Wu Q; Dan YL; Pan HF
Int J Rheum Dis; 2019 Oct; 22(10):1820-1824. PubMed ID: 31402566
[TBL] [Abstract][Full Text] [Related]
2. The involvement of galectin-3 in skin injury in systemic lupus erythematosus patients.
Shi Z; Meng Z; Han Y; Cao C; Tan G; Wang L
Lupus; 2018 Apr; 27(4):621-627. PubMed ID: 29058991
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients.
Wu GC; Li HM; Wang JB; Leng RX; Wang DG; Ye DQ
Lupus; 2016 Oct; 25(12):1377-80. PubMed ID: 27125292
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
[TBL] [Abstract][Full Text] [Related]
5. Plasma melatonin levels do not differ in SLE patients.
Wang P; Li HM; Zou YF; Tao JH; Pan HF
Z Rheumatol; 2018 Feb; 77(1):66-70. PubMed ID: 27444627
[TBL] [Abstract][Full Text] [Related]
6. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
[TBL] [Abstract][Full Text] [Related]
7. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
[TBL] [Abstract][Full Text] [Related]
8. Serum galectin-3 and galectin-3 binding protein levels in Behçet's disease and their association with disease activity.
Lee YJ; Kang SW; Song JK; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S41-5. PubMed ID: 17949550
[TBL] [Abstract][Full Text] [Related]
9. Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.
Panda AK; Parida JR; Tripathy R; Pattanaik SS; Ravindran B; Das BK
Arthritis Res Ther; 2012 Oct; 14(5):R218. PubMed ID: 23068019
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
[TBL] [Abstract][Full Text] [Related]
11. Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosus.
Wu Q; Yang Q; Sun H
Lupus; 2018 Nov; 27(13):2076-2085. PubMed ID: 30336754
[TBL] [Abstract][Full Text] [Related]
12. Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus.
Xiao JP; Wang XR; Zhang S; Wang J; Zhang C; Wang DG
Iran J Immunol; 2019 Mar; 16(1):43-52. PubMed ID: 30864554
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of adipokines in systemic lupus erythematosus patients.
Zhang TP; Li HM; Leng RX; Li XP; Li XM; Pan HF; Ye DQ
Cytokine; 2016 Oct; 86():15-20. PubMed ID: 27442006
[TBL] [Abstract][Full Text] [Related]
14. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
15. Serum galectin-3 level in systemic sclerosis.
Koca SS; Akbas F; Ozgen M; Yolbas S; Ilhan N; Gundogdu B; Isik A
Clin Rheumatol; 2014 Feb; 33(2):215-20. PubMed ID: 23912642
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
17. Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus.
Kalinska-Bienias A; Kowalczyk E; Bienias P; Gala K; Jagielski P; Kowalewski C
Postepy Dermatol Alergol; 2021 Apr; 38(2):274-280. PubMed ID: 34408596
[TBL] [Abstract][Full Text] [Related]
18. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
[TBL] [Abstract][Full Text] [Related]
19. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
20. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
